KALOBIOS INC has a total of 20 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Canada, United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are MEDICAL & BIOLOGICAL LABORATORIES CO LTD, X-BODY INC and X BODY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds | |
#6 | Combinatorial chemistry | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Her Jeng-Horng | 14 |
#2 | Balint Robert F | 13 |
#3 | Yarranton Geoffrey T | 4 |
#4 | Bebbington Christopher R | 4 |
#5 | Balint Robert R | 3 |
#6 | Luehrsen Kenneth R | 2 |
#7 | Flynn Peter | 2 |
#8 | Luehrsen Kenneth | 2 |
#9 | Bebbington Christopher Robert | 2 |
#10 | Yu Bo | 2 |
Publication | Filing date | Title |
---|---|---|
WO2005065348A2 | Transactivation system for mammalian cells | |
US2005008625A1 | Antibody affinity engineering by serial epitope-guided complementarity replacement | |
US2004038317A1 | Breakpoint fusion fragment complementation system | |
WO03068945A2 | Detection of molecular interaction by reactivation of an auto-inhibited responder (rair) | |
US2003157579A1 | Molecular sensors activated by disinhibition | |
CA2427747A1 | Affinity maturation by competitive selection |